Rare cancers are common: time to act-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Rare cancers are common: time to act

Published:2020-12-01 Issue:3 Volume:11 Page:1-2
ISSN:1792-362X
Container-title:Forum of Clinical Oncology
language:en
Short-container-title:

Author:

Liontos Michalis¹,Karamitrousis Evangelos²,Tsoukalas Nikolaos³,Boukovinas Ioannis⁴

Affiliation:

1. Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Alexandra Hospital , Athens , Greece

2. Department of Medical Oncology, Aristotle University of Thessaloniki, Papageorgiou General Hospital , Thessaloniki , Greece

3. Department of Oncology, 401 General Military Hospital , Athens , Greece

4. Department of Oncology, Bioclinic , Thessaloniki , Greece

Publisher

Walter de Gruyter GmbH

Subject

Oncology

Link

https://www.sciendo.com/pdf/10.2478/fco-2019-0024

Reference5 articles.

1. Casali P.G. and A. Trama, Rationale of the rare cancer list: a consensus paper from the Joint Action on Rare Cancers (JARC) of the European Union (EU). ESMO open, 2020. 5(2): e000666.

2. EU. [cited 2020 26/11/2020]; Available from: rarecacner.eu.

3. Gatta G., et al., Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet—a population-based study. The Lancet Oncology, 2017. 18(8): 1022-1039.

4. Pourtsidis A., et al. Acinar cell carcinoma in childhood: A case report of a very rare tumor. Forum Clin Oncol. 2020; 11(2):3-8.

5. Mohammad A, et al. Targeted therapy in advanced desmoid tumors: Current Perspectives. Forum Clin Oncol. 2020; 11(2):9-16.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP